Colton Center for Autoimmunity

Established by a generous gift from Judith and Stewart Colton, is dedicated to advancing innovative and translational research in autoimmune and allergic diseases. The center encourages cross-disciplinary, investigator-initiated research, to actively bridge gaps between research and application. It provides strategic support with the goal to advance research findings to a stage at which technology transfer to a commercial partner or start-up company is feasible. Under the direction of Dr. Joseph Craft, the center focuses on nurturing the development of novel diagnostics, therapies, and technology to alleviate autoimmune and allergic disorders, improving lives of patients and families.

About the COLTON Consortium

Our benefactors, Judith and Stewart Colton’s extraordinary generosity has catalyzed the creation of the Colton Consortium: The Colton Consortium—a partnership among the four Colton Centers at leading institutions including Penn, Yale, NYU, and Tel Aviv University—is a global initiative committed to transforming the prevention, diagnosis, treatment, and eventual cure of autoimmune disorders.

The mission of the Colton Consortium is to apply bold, collaborative, translational science to advance our mechanistic understanding of human autoimmunity. By engaging the most innovative scientists and physicians, the Consortium is committed to transforming discovery science, personalizing existing and novel therapies, and leveraging cutting-edge technology to better treat, cure, and prevent autoimmunity while improving patients’ health.

To learn more, visit the Colton Consortium.

News 

Our Scientific Expertise

Our team of leading investigators brings unmatched expertise in immunology, clinical research, and therapeutic development.

Contact our team to explore customized collaboration structures tailored to your strategic goals.

Get in Touch